Conestoga Capital Advisors’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-5,000
| Closed | -$335K | – | 140 |
|
2021
Q4 | $335K | Hold |
5,000
| – | – | ﹤0.01% | 131 |
|
2021
Q3 | $342K | Hold |
5,000
| – | – | ﹤0.01% | 132 |
|
2021
Q2 | $341K | Hold |
5,000
| – | – | ﹤0.01% | 128 |
|
2021
Q1 | $345K | Hold |
5,000
| – | – | 0.01% | 123 |
|
2020
Q4 | $325K | Hold |
5,000
| – | – | 0.01% | 131 |
|
2020
Q3 | $236K | Hold |
5,000
| – | – | ﹤0.01% | 139 |
|
2020
Q2 | $235K | Hold |
5,000
| – | – | 0.01% | 143 |
|
2020
Q1 | $223K | Hold |
5,000
| – | – | 0.01% | 137 |
|
2019
Q4 | $291K | Hold |
5,000
| – | – | 0.01% | 136 |
|
2019
Q3 | $300K | Hold |
5,000
| – | – | 0.01% | 124 |
|
2019
Q2 | $279K | Hold |
5,000
| – | – | 0.01% | 131 |
|
2019
Q1 | $279K | Hold |
5,000
| – | – | 0.01% | 128 |
|
2018
Q4 | $225K | Hold |
5,000
| – | – | 0.01% | 120 |
|
2018
Q3 | $329K | Hold |
5,000
| – | – | 0.01% | 108 |
|
2018
Q2 | $322K | Hold |
5,000
| – | – | 0.01% | 108 |
|
2018
Q1 | $277K | Hold |
5,000
| – | – | 0.01% | 112 |
|
2017
Q4 | $239K | Hold |
5,000
| – | – | 0.01% | 115 |
|
2017
Q3 | $252K | Hold |
5,000
| – | – | 0.01% | 107 |
|
2017
Q2 | $273K | Hold |
5,000
| – | – | 0.01% | 104 |
|
2017
Q1 | $211K | Sell |
5,000
-3,000
| -38% | -$127K | 0.01% | 110 |
|
2016
Q4 | $343K | Hold |
8,000
| – | – | 0.02% | 91 |
|
2016
Q3 | $330K | Hold |
8,000
| – | – | 0.02% | 90 |
|
2016
Q2 | $319K | Hold |
8,000
| – | – | 0.02% | 91 |
|
2016
Q1 | $269K | Hold |
8,000
| – | – | 0.02% | 93 |
|
2015
Q4 | $271K | Hold |
8,000
| – | – | 0.02% | 92 |
|
2015
Q3 | $238K | Sell |
8,000
-1,786
| -18% | -$53.1K | 0.02% | 100 |
|
2015
Q2 | $269K | Hold |
9,786
| – | – | 0.02% | 97 |
|
2015
Q1 | $247K | Hold |
9,786
| – | – | 0.02% | 103 |
|
2014
Q4 | $217K | Buy |
+9,786
| New | +$217K | 0.02% | 112 |
|